[PDF][PDF] The applications of PET in clinical oncology

LG Strauss, PS Conti - Journal of nuclear medicine, 1991 - Soc Nuclear Med
The colorectaltumor is one ofthe most common tumors in oncology. Abdominoperineal
resection of colorectal carcinoma is followed by local recurrence in 25%-30% of all …

Radiometals for combined imaging and therapy

CS Cutler, HM Hennkens, N Sisay… - Chemical …, 2013 - ACS Publications
The use of radionuclides in medicine is based largely on the discoveries of two critical
concepts, the “tracer principle” and the “magic bullet”. In 1913, George de Hevesy …

Efficient production of high specific activity 64Cu using a biomedical cyclotron

DW McCarthy, RE Shefer, RE Klinkowstein… - Nuclear medicine and …, 1997 - Elsevier
Copper-64 (T 1 2= 12.7 h) is an intermediate-lived positron-emitting radionuclide that is a
useful radiotracer for positron emission tomography (PET) as well as a promising …

Coordination compounds in nuclear medicine

S Jurisson, D Berning, W Jia, D Ma - Chemical reviews, 1993 - ACS Publications
Radiopharmaceuticals, drugs containing a radionu-clide, are used routinely in nuclear
medicine depart-ments for the diagnosis of disease and are under investigation for use in …

Copper radionuclides and radiopharmaceuticals in nuclear medicine

PJ Blower, JS Lewis, J Zweit - Nuclear medicine and biology, 1996 - Elsevier
The chemistry, radiochemistry, radiobiology, and radiopharmacology of
radiopharmaceuticals containing copper radionuclides are reviewed. Copper radionuclides …

Copper complexes of bis (thiosemicarbazones): from chemotherapeutics to diagnostic and therapeutic radiopharmaceuticals

BM Paterson, PS Donnelly - Chemical Society Reviews, 2011 - pubs.rsc.org
The molecules known as bis (thiosemicarbazones) derived from 1, 2-diones can act as
tetradentate ligands for Cu (II), forming stable, neutral complexes. As a family, these …

Copper bis (thiosemicarbazone) complexes as hypoxia imaging agents: structure-activity relationships

JL Dearling, JS Lewis, GE Mullen, MJ Welch… - JBIC Journal of …, 2002 - Springer
Copper (II) bis (thiosemicarbazone) complexes labelled with Cu-60/62/64 are useful
radiopharmaceuticals for imaging blood flow and hypoxic tissues in vivo. The aim of this …

Generator-based PET radiopharmaceuticals for molecular imaging of tumours: on the way to THERANOSTICS

F Rösch, RP Baum - Dalton transactions, 2011 - pubs.rsc.org
Generator-derived radionuclides for PET/CT imaging are promising for optimizing targeted
radiotherapy by an individual patient-based approach, applying pre-therapeutic evaluation …

[HTML][HTML] Uncovering disease mechanisms in a novel mouse model expressing humanized APOEε4 and Trem2* R47H

KP Kotredes, A Oblak, RS Pandey, PBC Lin… - Frontiers in Aging …, 2021 - frontiersin.org
Late-onset Alzheimer's disease (AD; LOAD) is the most common human neurodegenerative
disease, however, the availability and efficacy of disease-modifying interventions is severely …

[HTML][HTML] Radionuclide generators: The prospect of availing PET radiotracers to meet current clinical needs and future research demands

A Dash, R Chakravarty - American journal of nuclear medicine and …, 2019 - ncbi.nlm.nih.gov
Targeted molecular imaging with positron emission tomography (PET) constitutes a
successful technique for detecting and diagnosing disease conditions promptly and …